DAVID KIRSKE

CIK 1276750 · Chief Financial Officer · last filed 2026-05-13

DAVID KIRSKE is a Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing shows the insider sold $72.8K of XFOR on May 13, 2026. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $705.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$705.2K

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$1.83M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XFOR Chief Financial Officer 176,293 $4.00 $705.2K -$72.8K 3 2026-05-13
CTI BIOPHARMA CORP (CTIC) Delisted EVP, Chief Financial Officer 0 $9.09 $0 -$1.75M 17 2023-06-26

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-05-13 XFOR Sell (S) −16,961 -$72.8K EDGAR
2025-10-31 XFOR Grant (A) $0 EDGAR
2025-08-14 XFOR Grant (A) +193,254 $0 EDGAR
2023-06-26 CTI BIOPHARMA CORP (CTIC) Delisted Mixed −17,547 -$159.7K EDGAR
2023-03-16 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2023-01-03 CTI BIOPHARMA CORP (CTIC) Delisted Mixed +214 -$272.2K EDGAR
2022-10-06 CTI BIOPHARMA CORP (CTIC) Delisted Mixed -$11.2K EDGAR
2022-10-03 CTI BIOPHARMA CORP (CTIC) Delisted Mixed -$719.0K EDGAR
2022-09-20 CTI BIOPHARMA CORP (CTIC) Delisted Mixed +9,516 -$94.4K EDGAR
2022-06-17 CTI BIOPHARMA CORP (CTIC) Delisted Mixed -$197.5K EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.